Publikationen von Wilko Hinrichs

Wehr, M. C.; Hinrichs, W.; Brzózka, M. M.; Unterbarnscheidt, T.; Herholt, A.; Wintgens, J. P.; Papiol, S.; Soto-Bernardini, M. C.; Kravchenko, M.; Zhang, M. et al.; Nave, K.-A.; Wichert, S. P.; Falkai, P.; Zhang, W.; Schwab, M. H.; Rossner, M. J.: Spironolactone is an antagonist of NRG1-ERBB4 signaling and schizophrenia-relevant endophenotypes in mice. Embo Molecular Medicine 9 (10), S. 1448 - 1462 (2017)

Velanac, V.; Unterbarnscheidt, T.; Hinrichs, W.; Gummert, M. N.; Fischer, T.; Rossner, M. J.; Trimarco, A.; Brivio, V.; Taveggia, C.; Willem, M. et al.; Haass, C.; Möbius, W.; Nave, K.-A.; Schwab, M. H.: BACE1 processing of NRG1 type III produces a myelin-inducing signal but is not essential for the stimulation of myelination. Glia 60 (2), 10.1002/glia.21255, S. 203 - 217 (2012)

Hinrichs, W.: A cell-based NRG1-ERBB4 assay designed for high-throughput compound screening to identify small molecule modulators with relevance for schizophrenia. Dissertation, Georg-August-Universität, Göttingen (2012)